DWK Life Sciences acquires Müller + Müller-Joh. GmbH + Co. KG
The world’s leading manufacturer of laboratory glass and life science packaging materials, DWK Life Sciences, announces the signing of a definitive purchase agreement of Müller + Müller at August 21st, 2020.
Müller + Müller is one of the leading German manufacturers of primary packaging materials made of tubular glass for the pharmaceutical industry.
The company will become part of the DWK Life Sciences group upon closing, which is expected for September. Müller + Müller will continue to serve its customers under the same name and will continue to be managed by CEO Florian Müller-Stauch.
Dr. Hubertus Müller-Stauch (owner of the company Müller + Müller) will join the advisory board of DWK Life Sciences to support the further expansion of the pharma packaging division.
Müller + Müller is based in Holzminden in Lower Saxony, Germany, and currently employs 135 staff. The family-run company is a key player in the manufacture of vials and has a long history of over 95 years.
Thanks to its state-of-the-art technology and continuous process optimisation, Müller + Müller meets the highest quality requirements for pharmaceutical packaging.
Every year approx. 300 million glass type I vials are produced at its Holzminden site in accordance with GMP guidelines.
Type I borosilicate glass is an excellent material for storing vaccines as the glass is virtually inert. This means that the container glass does not react with its contents and thus represents the standard in vaccine packaging.
"Acquiring the family business Müller + Müller is a significant strategic step for us in expanding our activities in the market for pharmaceuticals packaging,” explains CEO of DWK Life Sciences, Armin Reiche.
“We are not just investing in an important growth market here, but also in a company that boasts first class production technology and highly reliable products."
"Driven by the high demand of the vaccine industry for vials, expansion of our production capacities is the next logical step,” says Florian Müller-Stauch, CEO of Müller + Müller.
“We are delighted to have found a strong and reliable partner in DWK who will allow us to further develop our business."
DWK Life Sciences is a portfolio company of One Equity Partners, a middle market private equity firm that builds market-leading companies by identifying and executing transformative business combinations and partnering with management teams to provide operational support to accelerate growth.
About Müller + Müller
Müller + Müller is one of the world’s leading manufacturers of primary packaging materials made of tubular glass for the pharmaceuticals industry.
Its clear focus and over 90 years of experience in the field of tubular glass vials show that the company is well positioned to be a reliable and growth-minded partner to its customers in the future.
Its manufacturing base in Holzminden (southern Lower Saxony) produces approx. 300 million vials every year on state-of-the-art production lines. Production meets the highest quality standards and complies with DIN EN ISO 9001:2008 and DIN ISO 15378:2011 (GMP standard).
About DWK Life Sciences
DWK Life Sciences is a leading global manufacturer and supplier of precision labware as well as storage and packaging solutions for a wide range of scientific and industrial applications.
The DWK Life Sciences offering includes over 30,000 glass and plastics products, manufactured at 12 sites, marketed under the acclaimed brands DURAN®, WHEATON® and KIMBLE®.
Its world-leading and trusted glass is complemented by an innovative research and life science portfolio.
Worldwide, 1,700 people are dedicated to developing and delivering superior products and services that focus on the needs of our customers in Research, Life Sciences, Health Care, and Industrial markets.
For more information contact DWK Life Sciences on communications@DWK.com